z-logo
open-access-imgOpen Access
Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings
Author(s) -
Marcello Moro Queiroz,
Rodrigo Ramella Munhoz,
Cibele Masotti,
Larissa M. Souza,
Luiz Guilherme Cernaglia Aureliano de Lima,
Paula Fontes Asprino,
María Dirlei Begnami,
Anamaria A. Camargo,
Fabiana Bettoni
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.22.00163
Subject(s) - immunohistochemistry , nivolumab , sarcomatoid carcinoma , medicine , hepatocellular carcinoma , pathology , cancer research , pd l1 , oncology , cancer , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom